Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2018
Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in GlioblastomaYiru Zhang, Chiaki Tsuge Ishida, Wataru Ishida, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2018
Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in GlioblastomaChiaki T Ishida, Yiru Zhang, Elena Bianchetti, et al.EMBO Molecular Medicine|August 31, 2019
Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl-xL inhibitionTrang Thi Thu Nguyen, Chiaki Tsuge Ishida, Enyuan Shang, et al.Nature Communications|September 2, 2021
Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastomaTrang T T Nguyen, Enyuan Shang, Chang Shu, et al.Biorxiv : the Preprint Server for Biology|February 12, 2026
IDH-mutant inhibitors enhance the sensitivity of IDH1-mutant gliomas to cysteine-methionine deprivation and ferroptosisAngeliki Mela, Abby Brand, Aayushi Mahajan, et al.Cancer Research|November 8, 2019
MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in GlioblastomaYiru Zhang, Trang T T Nguyen, Enyuan Shang, et al.Journal of the National Cancer Institute|February 5, 2015
Adaptive mitochondrial reprogramming and resistance to PI3K therapyJagadish C Ghosh, Markus D Siegelin, Valentina Vaira, et al.Scientific Reports|April 5, 2018
Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approachMelanie Mettang, Viola Meyer-Pannwitt, Georg Karpel-Massler, et al.The Journal of Clinical Investigation|April 22, 2020
HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma modelsTrang Thi Thu Nguyen, Yiru Zhang, Enyuan Shang, et al.JAMA Oncology|May 18, 2023
Association of MGMT Promoter Methylation With Survival in Low-grade and Anaplastic Gliomas After Alkylating ChemotherapyConnor J Kinslow, Ann Mercurio, Prashanth Kumar, et al.Pageof 9